Targeted therapy is an important method in the treatment of lung cancer, especially in the detection of common NSCLC mutations such as epidermal growth factor receptor (EGFR), rat sarcoma viral oncogene (KRAS), anaplastic lymphoma kinase (ALK), and BRAF genes.33 This evidence concerns the gene EGFR and lung cancer.